Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Avai Bio (AVAI) EPS (Weighted Average and Diluted) (2018 - 2020)

Avai Bio's EPS (Weighted Average and Diluted) history spans 3 years, with the latest figure at $0.02 for Q4 2020.

  • For Q4 2020, EPS (Weighted Average and Diluted) rose 882.96% year-over-year to $0.02; the TTM value through Dec 2020 reached $0.02, up 882.96%, while the annual FY2020 figure was -$0.07, 305.46% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2020 was $0.02 at Avai Bio, up from $0.0 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.02 in Q4 2020 and bottomed at -$0.03 in Q3 2018.
  • The 3-year median for EPS (Weighted Average and Diluted) is -$0.0 (2019), against an average of -$0.0.
  • The largest annual shift saw EPS (Weighted Average and Diluted) tumbled 77.97% in 2019 before it skyrocketed 882.96% in 2020.
  • A 3-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.0 in 2018, then surged by 46.52% to -$0.0 in 2019, then soared by 882.96% to $0.02 in 2020.
  • Per Business Quant, the three most recent readings for AVAI's EPS (Weighted Average and Diluted) are $0.02 (Q4 2020), $0.0 (Q3 2020), and $0.0 (Q2 2020).